Project Grant HT94252310943

Under a $1,525,000 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development), the University of Florida's Division of Sponsored Research will conduct research to "UNDERSTANDING AND TARGETING COMMON MECHANISMS OF MYOTONIC DYSTROPHY TYPES 1AND 2 USING NOVEL REPEAT EXPANSION MOUSE MODELS." This 4-year research project, commencing on Sep 1, 2023, will advance the understanding and treatment of myotonic dystrophy, a genetic disorder that causes progressive muscle wasting and weakness. The University of Florida, a leading public research institution, will leverage its expertise in biomedical research to investigate the underlying mechanisms of this disease and explore novel therapeutic approaches using animal models. Findings from this grant-funded work are expected to transform healthcare for service members, veterans, and the broader public affected by this disabling condition.